• Uriel238 [all pronouns]@lemmy.blahaj.zone
    link
    fedilink
    English
    arrow-up
    10
    ·
    5 months ago

    LLMs are less magical than upper management wants them to be, which is to say they won’t replace the creative staff that makes art and copy and movie scripts, but they are useful as a tool for those creatives to do their thing. The scary thing was not that LLMs can take tons of examples and create a Simpsons version of Cortana, but that our business leaders are super eager to replace their work staff with the slightest promise of automation.

    But yes, LLMs are figuring in advancements of science and engineering, including treatments for Alzheimer’s and diabetes. So it’s not just a parlor trick, rather one that has different useful applications that were originally sold to us.

    The power problem (LLMs take a lot of power) remains an issue.

    • TheOubliette@lemmy.ml
      link
      fedilink
      arrow-up
      3
      ·
      5 months ago

      I’m unaware of any substantial research on Alzheimer’s or diabetes that has been done using LLMs. As generative models they’re basically just souped up Markov chains. I think the best you could hope for is something like a meta study that is probably a bit worse than the usual kind.

      • earmuff@lemmy.dbzer0.com
        link
        fedilink
        arrow-up
        3
        ·
        5 months ago

        I agree, things that occure the most in the training data set will have the highest weights/probabilities in the Markov chain. So it is useless in finding the one, tiny relation that humans would not see.